中国动脉粥样硬化网 >> 网站地图 >> 第92页:
http://www.sinoas.com/SiteMap/Article002.htm
  • 螺内酯可减少肾病患者的蛋白尿Spironolactone Reduces Proteinuria in Renal Disease
  • 他汀类药物可降低血液透析患者的死亡率Statins Reduce Mortality in Hemodialysis Patients
  • 蛋白尿是肾病和心血管病的独立危险指标Protein is an Independent Risk Marker for Kidney and Cardiovascular Disease
  • 早期肾衰常见冠状动脉钙化Coronary Artery Calcification Common in Early Renal Failure
  • CDC研究夸大了归因于肥胖的死亡数CDC study overstates number of deaths attributable to obesity
  • 代谢综合症在美国青少年中很常见Metabolic Syndrome Common in Adolescents
  • 肾动脉介入手术例数明显增加Dramatic increase in renal artery interventional procedures found
  • 贝特和格列酮合用可降低血浆HDL胆固醇Fibrate Plus Glitazone May Lower Serum HDL Cholesterol
  • 美国成人代谢综合症的发病增加Metabolic Syndrome on the Rise in US Adults
  • 心脏病人中肾脏疾病经常被忽视Kidney Disease Often Overlooked in Heart Patients
  • 心脏肌钙蛋白T预测肾脏病人的心血管风险Cardiac Troponin T Points to Cardiovascular Risk in Kidney Disease
  • 慢性肾脏疾病增加了多个心血管疾病危险因素The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease.
  • 降糖药可能会掩盖心脏病发作的严重性Diabetes drugs can mask severity of heart attack
  • 损害心脏的因素同样损害肾脏What Hurts the Heart Also Hurts the Kidney
  • 血管造影术有利于所有早期急性冠脉综合症患者Early ACS angiography supported for all
  • 阿托伐他汀可预防高胆固醇血症引起的主动脉瓣膜钙化Atorvastatin Prevents Hypercholesterolemic Aortic Valve Calcification
  • 胺碘酮治疗房颤优于索他洛尔Amiodarone Beats Sotalol for AF
  • BMI 升高是房颤的危险因素Raised BMI an AF Risk Factor
  • 危险评分可识别早期冠心病的危险Risk Score Identifies Early CHD Risk
  • 依泽替米贝/辛伐他汀复方优于阿托伐他汀Ezetimibe/Simvastatin Combination Superior to Atorvastatin
  • 坚持他汀治疗对于糖尿病血脂水平达标至关重要Statin Adherence Central to Diabetic Dyslipidemia Goal Attainment
  • OxLDL抗体可反映晚期糖尿病的动脉粥样硬化OxLDL Antibodies Reflect Advanced Diabetic Atherosclerosis
  • 非诺贝特可延缓糖尿病患者进展到微白蛋白尿Fenofibrate Slows Progression to Microalbuminuria in Diabetic Patients
  • 糖尿病患者发生冠心病的危险未被充分控制Diabetes CHD Risk Management Suboptimal
  • 补充铬并不能改善受损的糖耐量Chromium Supplementation May Not Improve Impaired Glucose Tolerance
  • 糖尿病女性在冠心病预防中处于不利位置Diabetic Women Disadvantaged in CHD Prevention
  • 合理而积极地进行冠心病患者的调脂治疗
  • ACE抑制剂治疗冠心病心绞痛循证医学证据与治疗指南的衍变
  • 运动和应激处理训练对缺血性心脏病患者心血管危险指标的影响Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients With Ischemic Heart Disease
  • 在ST段抬高型心梗患者再灌注治疗前，高血糖是冠脉血流受损的一项重要预测指标Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
  • 热休克蛋白70可作为心梗的标记物Heat Shock Protein 70 May Make MI Marker
  • 依泽替米贝可增强辛伐他汀的血管保护作用Ezetimibe May Potentiate Vasculoprotective Effects of Simvastatin
  • 高血压患者发生急性心肌梗死后的住院预后更佳Hypertensive Patients Have Better In-Hospital Outcomes After Acute MI
  • 卡维地洛与ACE抑制剂合用可预防心梗后心律失常Carvedilol Works With ACE Inhibitors to Prevent Arrhythmias After MI
  • AMI药物强化治疗的效果与介入治疗相当Intensive AMI Medical Treatment Equals Invasive Strategy
  • 体外循环和非体外循环下冠脉搭桥术后的左心室舒张功能相似Left Ventricular Diastolic Function Similar After On-Pump and Off-Pump CABG
  • 载脂蛋白B可预测中年人冠脉事件Apolipoprotein B Predicts Coronary Events in Middle-Aged Adults
  • 汀加氯吡格雷对急性冠脉综合征患者有协同益处Statins Plus Clopidogrel Offer Synergistic ACS Benefits
  • 边缘危险因素对于冠心病并不重要Borderline Risk Factors of Little Importance in CHD
  • 他汀显示出对ACS有早期和重大的抗炎效果Statins Show Early and Important Anti-Inflammatory Effects in ACS
  • 依泽替米贝加非诺贝特可治疗混合型高脂血症Ezetimibe plus fenofibrate useful in mixed hyperlipidemia
  • 氯吡格雷用于急性冠脉综合征后第一年的费效关系佳Clopidogrel Cost-Effective During First Year After Acute Coronary Syndrome
  • AMI药物强化治疗的效果与介入治疗相当Intensive AMI Medical Treatment Equals Invasive Strategy
  • 依泽替米贝可增强辛伐他汀的血管保护作用Ezetimibe May Potentiate Vasculoprotective Effects of Simvastatin
  • 维生素E未能改善糖尿病患者的内皮或左心室功能Vitamin E Unlikely to Improve Endothelial or LV Function in Diabetics
  • 阿托伐他汀强化降脂治疗稳定型冠心病Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
  • 非致死性心梗对严重心力衰竭患者预后的影响以及布新洛尔的治疗效果Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy
  • 氯吡格雷作为辅助再灌注治疗——心肌梗死溶栓（CLARITY-TIMI）28试验的设计和基本原理Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy性hrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial
  • 带有人工瓣膜的金黄色葡萄球菌菌血症患者罹患心内膜炎的危险Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia
  • 高胆固醇血症和高血压对动脉的影响不同Hypercholesterolemia and Hypertension Affect Arteries Differently
  • 西地那非可以阻止和逆转小鼠的心脏肥大Sildenafil Prevents and Reverses Cardiac Hypertrophy in Mice
  • STEMI可受益于低分子量肝素STEMI Benefits From LMWH
  • 体外循环和非体外循环下冠脉搭桥术后的左心室舒张功能相似Left Ventricular Diastolic Function Similar After On-Pump and Off-Pump CABG
  • 边缘危险因素对于冠心病并不重要Borderline Risk Factors of Little Importance in CHD
  • 载脂蛋白B可预测中年人冠脉事件Apolipoprotein B Predicts Coronary Events in Middle-Aged Adults
  • 补充铬并不能改善受损的糖耐量Chromium Supplementation May Not Improve Impaired Glucose Tolerance
  • ACC年会：氯吡格雷可降低急性心梗的危险Clopidogrel cuts AMI risk
  • ACC年会：REALITY试验发现药物涂层支架的疗效相似Drug-Eluting Stents Similar in REALITY
  • 他汀加氯吡格雷对急性冠脉综合征患者有协同益处Statins plus clopidogrel offer synergistic ACS benefits
  • 脂联素对1型糖尿病患者的冠心病有“保护作用”Adiponectin CAD Protective in Type 1 Diabetes
  • 糖尿病血脂异常的治疗最好有严格目标Stringent Targets Best for Diabetic Dyslipidemia
  • HDL胆固醇和甘油三酯可预测糖尿病患者发生冠心病的危险HDL Cholesterol and Triglycerides Drive CAD Risk in Diabetics
  • 哪个对CAD患者更有利，CCB还是ACEI?Which One Provides More Benefits for CAD Patients, CCB or ACEI?
  • 接受冠脉搭桥手术后患者的心脏药物治疗对随机对照试验的综述Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery A review of randomized controlled trials
  • 曲美他嗪对缺血性扩张性心肌病患者的长期心脏保护作用及对炎症过程的潜在作用Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
  • 经皮冠脉介入治疗后长期应用氯吡格雷治疗的经济学效果Economic effects of prolonged clopidogrel therapy after percutaneous coronary intervention
  • 胺碘酮或者植入式心脏复律除颤器在充血性心力衰竭患者中的应用Amiodarone or an Implantable Cardioverter心efibrillator for Congestive Heart Failure
  • 荟萃分析证实激素替代疗法增加了缺血性卒中的危险Meta-Analysis Confirms HRT Increases Ischemic Stroke Risk
  • 治疗NSTE-ACS的简化字母表方法Alphabet Guidelines Treat NSTE-ACS
  • 升高HDL可能限制斑块进展，降低心脏事件危险Raising HDL May Limit Plaque Progression, Reduce Risk of Cardiac Events
  • 抗炎蛋白水平增高可降低心梗危险High Levels of Anti-Inflammatory Protein Cut MI Risk
  • 女性的PCI死亡危险与男性相似PCI Death Risks Similar between Genders
  • 双腔心脏复律器对心律失常的检测没有特别的帮助Dual-Chamber Cardioverter Approach No Extra Help in Arrhythmia Detection
  • 高血压患者的微血管适应被破坏Microvascular Adaptation Disturbed in Hypertensives
  • 休克蛋白70可作为心梗的标记物Heat Shock Protein 70 May Make MI Marker
  • 西地那非可以阻止和逆转小鼠的心脏肥大Sildenafil Prevents and Reverses Cardiac Hypertrophy in Mice
  • STEMI可受益于低分子量肝素STEMI Benefits from LMWH
  • 新的证据表明应加强对不稳定CAD的早期介入治疗New Findings Strengthen the Case for Early Intervention in Unstable CAD
  • 治疗NSTE-ACS的简化字母表方法Alphabet Guidelines Treat NSTE-ACS
  • 升高HDL可能限制斑块进展，降低心脏事件危险Raising HDL May Limit Plaque Progression, Reduce Risk of Cardiac Events
  • 新检测到的血糖异常可预示心梗后的心脏事件Newly Detected Glucose Abnormalities Predict Future Cardiac Events After MI
  • CRAVT：一项前瞻性、随机研究比较房室结折返性心动过速患者使用经静脉冷冻疗法和射频消融疗法CRAVT: a prospective, randomized study comparing transvenous cryothermal and radiofrequency ablation in atrioventricular nodal re-entrant tachycardia
  • 使用西洛他唑、氯吡格雷或噻氯匹定预防亚急性支架栓塞：随机试验的荟萃分析Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trials
  • 多巴酚丁胺负荷超声心动图后7年随访——性别对预后的影响Seven-year follow-up after dobutamine stress echocardiography——Impact of gender on prognosis
  • 内皮微颗粒与急性冠脉综合征患者中血管造影证明的高危病变有关Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes
  • AMI死亡率的性别差异并非只归因于AMI严重性的不同AMI Severity Does Not Explain Gender Differences
  • 冠心病常常伴有代谢综合征Coronary Disease Often Accompanies Metabolic Syndrome
  • 二尖瓣脱垂与腹腔动脉狭窄密切相关Mitral Valve Prolapse Tied to Celiac Artery Stenosis
  • 血管对血管紧张素II的反应下降可预测CABG后的心血管事件Diminished Vascular Response to Ang II Predicts CV Events After CABG
  • 停用NSAID治疗后数周心梗的危险增加Risk of MI Increased for Several Weeks After Stopping NSAID Therapy


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
    26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
    51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
    76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 [92] 93 94 95 96 97 98 99 100
    101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
    126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150
    151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
    176 177 178 179 180 181 182